共 34 条
[2]
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data
[J].
PLOS ONE,
2015, 10 (06)
[3]
B lymphocytes in neuromyelitis optica
[J].
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION,
2015, 2 (03)
:e104
[4]
Brinkmann Volker, 2010, J Vis Exp, DOI 10.3791/1724
[7]
Graf J., 2021, NEUROL NEUROIMMUNOL, V8
[8]
Graf J, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000000918
[9]
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
[J].
JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB,
2022, 25
:53-60
[10]
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera®) in patients with CD20-positive B-cell non-Hodgkin lymphoma
[J].
CHINESE JOURNAL OF CANCER RESEARCH,
2022, 34 (06)
:601-611